The
prostaglandin J2 derivative 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) is a very active compound with important effects on
inflammation, apoptosis, and cell growth processes. To exert this broad range of effects,
15d-PGJ2 binds and alters the activity of diverse
proteins, which consequently are postulated to be mediators of its action. Among them are the
transcription factors peroxisome proliferator-activated receptor gamma and
nuclear factor kappaB, which are thought to play an essential role in the antitumorigenic and anti-inflammatory actions of
15d-PGJ2. Here, we show that
15d-PGJ2, at micromolar concentrations, efficiently blocks state 3 oxygen consumption in intact nonsynaptic mitochondria isolated from rat cerebral cortex. This effect is attributable to the inhibition by this
prostaglandin of the activity of the
enzyme NADH-ubiquinone reductase (complex I) of the mitochondrial respiratory chain. In addition to this,
15d-PGJ2 dramatically increases the rate of
reactive oxygen species generation by complex I. The inhibition by
15d-PGJ2 of complex I activity was abolished by
dithiothreitol, which raises the possibility that adduct formation with a critical component of complex I accounts for the inhibitory effect of this
prostaglandin. These results clearly identified mitochondrial complex I as a new target for
15d-PGJ2 actions.